Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
出版年份 2018 全文链接
标题
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
作者
关键词
-
出版物
Nature Protocols
Volume 13, Issue 2, Pages 335-357
出版商
Springer Nature
发表日期
2018-01-19
DOI
10.1038/nprot.2017.130
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- Driving gene-engineered T cell immunotherapy of cancer
- (2016) Laura A Johnson et al. CELL RESEARCH
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+T cells
- (2016) Ravikumar Muthuswamy et al. PROSTATE
- Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
- (2016) Lily Francis et al. Oncotarget
- Synergistic COX2 Induction by IFN and TNF Self-Limits Type-1 Immunity in the Human Tumor Microenvironment
- (2016) J. L. Wong et al. Cancer Immunology Research
- Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
- (2016) Michal Radomski et al. Journal for ImmunoTherapy of Cancer
- Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
- (2015) Stephanie Downs-Canner et al. ANNALS OF SURGICAL ONCOLOGY
- Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
- (2015) Angela Vasaturo et al. IMMUNOBIOLOGY
- Toward improved effectiveness of bladder cancer immunotherapy
- (2015) Pawel Kalinski et al. Immunotherapy
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Evolution of animal models in cancer vaccine development
- (2015) Wei-Zen Wei et al. VACCINE
- Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
- (2015) Jashodeep Datta et al. Frontiers in Immunology
- Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models
- (2015) Soledad Mac Keon et al. Frontiers in Immunology
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Consensus nomenclature for CD8+T cell phenotypes in cancer
- (2015) Lionel Apetoh et al. OncoImmunology
- Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
- (2015) Ravikumar Muthuswamy et al. Journal for ImmunoTherapy of Cancer
- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy
- (2014) Jennifer A Westwood et al. OncoImmunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
- (2013) Pawel Kalinski et al. Expert Review of Vaccines
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
- (2013) Beatriz M. Carreno et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis
- (2013) Pragatheeshwar Thirunavukarasu et al. MOLECULAR THERAPY
- Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy
- (2013) Christel Devaud et al. MOLECULAR THERAPY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
- (2013) Christel Devaud et al. OncoImmunology
- IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients
- (2013) Jeffrey L. Wong et al. OncoImmunology
- Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
- (2012) L. B. John et al. CANCER RESEARCH
- NF- B Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
- (2012) R. Muthuswamy et al. CANCER RESEARCH
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunobiology of human mucin 1 in a preclinical ovarian tumor model
- (2012) R A Budiu et al. ONCOGENE
- Type I interferon response and innate immune sensing of cancer
- (2012) Mercedes B. Fuertes et al. TRENDS IN IMMUNOLOGY
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumor Activity Mediated by CpG
- (2011) Yanyan Lou et al. JOURNAL OF IMMUNOTHERAPY
- PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
- (2011) Jacalyn Rosenblatt et al. JOURNAL OF IMMUNOTHERAPY
- Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
- (2011) Cheryl L-L Chiang et al. Journal of Translational Medicine
- Defining the critical hurdles in cancer immunotherapy
- (2011) Bernard A Fox et al. Journal of Translational Medicine
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
- (2011) Jun Li et al. MOLECULAR THERAPY
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- New flow cytometric assays for monitoring cell-mediated cytotoxicity
- (2010) Liubov Zaritskaya et al. Expert Review of Vaccines
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
- (2010) Elizabeth D. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
- (2010) Konrad Wilhelm et al. NATURE MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8+ T cells against prostate cancer cells and defined prostate cancer-specific epitopes
- (2010) Eva Wieckowski et al. PROSTATE
- Signaling Through OX40 Enhances Antitumor Immunity
- (2010) Shawn M. Jensen et al. SEMINARS IN ONCOLOGY
- Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines
- (2009) Adam S. Giermasz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
- (2009) A. Ribas et al. CLINICAL CANCER RESEARCH
- Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells
- (2009) P. B. Watchmaker et al. JOURNAL OF IMMUNOLOGY
- Development of a Potency Assay for Human Dendritic Cells: IL-12p70 Production
- (2009) Lisa H. Butterfield et al. JOURNAL OF IMMUNOTHERAPY
- Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine
- (2008) K. Gustafsson et al. CANCER RESEARCH
- Using Dendritic Cell Maturation and IL-12 Producing Capacity as Markers of Function: A Cautionary Tale
- (2008) Anjum S. Kaka et al. JOURNAL OF IMMUNOTHERAPY
- Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
- (2008) Je-Jung Lee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+T cells in lymphocyte-rich gastric carcinoma
- (2008) H Ohtani et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More